Class III beta-tubulin expression predicts prostate tumor aggressiveness and patient response to docetaxel-based chemotherapy

Expression of class III β-tubulin (βIII-tubulin) correlates with tumor progression and resistance to taxane-based therapies for several human malignancies but its use as a biomarker of tumor behaviour in prostate cancer (PCa) remains largely unexplored. Here, we describe βIII-tubulin immunohistochem...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ploussard, Guillaume, Terry, Stéphane, Maillé, Pascale, Allory, Yves, Sirab, Nanor, Kheuang, Laurence, Soyeux, Pascale, Nicolaiew, Nathalie, Coppolani, Estelle, Paule, Bernard, Salomon, Laurent J., Culine, Stéphane, Buttyan, Ralph, Vacherot, Francis, De La Taille, Alexandre
Format: Artigo
Idioma:Inglês
Publicat: American Association for Cancer Research 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3290526/
https://ncbi.nlm.nih.gov/pubmed/21045157
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-10-1447
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars